Breast CAncer

Endocrine Therapy for Hormone Receptor-Positive Breast Cancer in Men

By

Vicki Moore, PhD

Publish Date May 5, 2021

Results of the phase 2 MALE clinical trial comparing 3 treatment regimens in men with hormone-receptor positive breast cancer are reported.

Cancer Diagnoses Increase at Age 65, Decrease Immediately Afterward

By

Colby Stong

Publish Date May 5, 2021

The largest increase in cancer diagnosis at age 65 years was in stage I for all breast cancer, colon cancer, prostate cancer, and lung cancer.

Benefit Seen With Ribociclib in Most Breast Cancer Subtypes

By

Andrea S. Blevins Primeau, PhD, MBA

Publish Date April 19, 2021

A team of investigators conducted a retrospective study to determine the relationship of intrinsic breast cancer subtypes on survival in patients undergoing endocrine therapy plus ribociclib.

Unplanned Implant Removal Following Treatment for Locally Advanced Breast Cancer

By

Leah Lawrence

Publish Date April 16, 2021

A team of investigators assessed the frequency and timing of unplanned breast implant removal in patients undergoing with mastectomy, reconstruction, and postmastectomy radiation therapy for locally advanced breast cancer.

Effects of Treatment, Inactivity on Arm Tissue Composition in Survivors of Breast Cancer

By

Vicki Moore, PhD

Publish Date March 29, 2021

Results of an assessment of tissue composition changes experienced by breast cancer survivors without lymphedema are presented.

Adjuvant Abemaciclib Plus Endocrine Therapy Maintains Patient-Reported Outcomes in Early Breast Cancer

By

Christina Bennett, MS

Publish Date March 25, 2021

Results from the phase 3 monarchE trial on the addition of abemaciclib to endocrine therapy in patients with early breast cancer were presented at the 17th St. Gillen International Breast Cancer Conference.

Upfront Niraparib Showed Antitumor Activity in BRCA-Mutated Breast Cancer

By

Christina Bennett, MS

Publish Date March 22, 2021

A team of investigators sought to evaluate safety, tolerability, and antitumor activity neoadjuvant niraparib for patients with localized breast cancer.

MRI Yields Most Concordant Breast Cancer Tumor Size Assessment

By

Colby Stong

Publish Date March 22, 2021

A team of investigators sought to identify the most accurate preoperative breast imaging technique for determining tumor size in individuals with early breast cancer.

Breast Cancer Screening Improves Survival in Women With BRCA1/2 Mutations

By

Christina Bennett, MS

Publish Date March 22, 2021

A team of researches sought to assess the effectiveness of breast cancer surveillance among patients with BRCA1/2 mutations.

Strategy for Assessing Axillary Adenopathy on Mammography Following COVID-19 Vaccination

By

Vicki Moore, PhD

Publish Date March 5, 2021

A team of radiologists explain their strategy for maintaining breast cancer screening in women with managing a potential side effect of vaccination.